Year |
Citation |
Score |
2014 |
Whitley A, Cooper T, Angajala A, Trummell H, Jackson J, Bonner JA, Yang ES. Radiosensitization by erlotinib and veliparib in esophageal squamous cell cancer. Journal of Clinical Oncology. 32: 70-70. DOI: 10.1200/Jco.2014.32.3_Suppl.70 |
0.38 |
|
2014 |
Taylor R, Whitley A, Baden C, Lopez-Araujo J, Shen S, Burnett O, De Los Santos J, Kim R. High-Dose-Rate Interstitial Brachytherapy for Gynecologic Cancer: Fistula Formation Relating to Differential Dose Tolerance of Proximal and Distal Vagina International Journal of Radiation Oncology*Biology*Physics. 90: S186. DOI: 10.1016/J.Ijrobp.2014.05.713 |
0.315 |
|
2013 |
Whitley A, Dragovic A, Shen S, Wu S, Kim R. Effects of Full Versus Empty Bladder on Total Equivalent Dose to Organs at Risk in 3D Image-Based Planning of High-Dose-Rate Intracavitary Brachytherapy for Cervical Cancer International Journal of Radiation Oncology*Biology*Physics. 87: S404. DOI: 10.1016/J.Ijrobp.2013.06.1061 |
0.308 |
|
2012 |
Nowsheen S, Whitley AC, Yang ES. Biomarkers to assess the targeting of DNA repair pathways to augment tumor response to therapy. Current Molecular Medicine. 12: 788-803. PMID 22292444 DOI: 10.2174/156652412800792615 |
0.311 |
|
2012 |
Whitley A, Nowsheen S, Cooper T, LoBuglio A, Bonner J, Yang ES. Abstract 4684: Synthetic lethal interaction between EGFR and PARP inhibition Cancer Research. 72: 4684-4684. DOI: 10.1158/1538-7445.Am2012-4684 |
0.371 |
|
2012 |
Whitley A, Jackson J, Trummell H, Bonner J, Yang E. Erlotinib Induces Synthetic Lethality With the Poly(ADP-Ribose) Polymerase (PARP) Inhibitor ABT-888 in Esophageal Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S165-S166. DOI: 10.1016/J.Ijrobp.2012.07.428 |
0.344 |
|
2012 |
Shen S, Kim R, Whitley A, Dragovic A, Wu X. Interfractional Variation of Hot Spot Locations for Organs at Risk in High-dose-rate Brachytherapy for Cervical Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S444. DOI: 10.1016/J.Ijrobp.2012.07.1175 |
0.338 |
|
2012 |
Lopez-Araujo J, Dragovic AF, Santos JFDL, Msadabwe-Chikuni SC, Spencer SA, Burnett OL, Whitley AC, Kim RY. The Importance of Overall Treatment Time in the Era of Concurrent Chemoradiation Therapy for Locally Advanced Cervical Cancer International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.1174 |
0.315 |
|
2012 |
Chikuni SM, Whitley AC, López-Araujo JJ, Santos JFDL, Burnett LO, Spencer SA, Kim RY. Comparison of 2 Dose Fractionation Regimens of High-dose-rate Brachytherapy in the Treatment of Cervical Cancer International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.1172 |
0.332 |
|
2011 |
Nowsheen S, Bonner JA, Lobuglio AF, Trummell H, Whitley AC, Dobelbower MC, Yang ES. Cetuximab augments cytotoxicity with poly (adp-ribose) polymerase inhibition in head and neck cancer. Plos One. 6: e24148. PMID 21912620 DOI: 10.1371/Journal.Pone.0024148 |
0.409 |
|
2011 |
Whitley AC, Nowsheen S, Trummell H, LoBuglio A, Bonner JA, Yang ES. Abstract 5496: Cetuximab induces synthetic lethality with the poly (ADP-Ribose) polymerase (PARP) inhibitor ABT-888 in head and neck cancer Cancer Research. 71: 5496-5496. DOI: 10.1158/1538-7445.Am2011-5496 |
0.408 |
|
2006 |
Whitley AC, Sweet DH, Walle T. Site-specific accumulation of the cancer preventive dietary polyphenol ellagic acid in epithelial cells of the aerodigestive tract. The Journal of Pharmacy and Pharmacology. 58: 1201-9. PMID 16945178 DOI: 10.1211/Jpp.58.9.0006 |
0.538 |
|
2005 |
Whitley AC, Sweet DH, Walle T. The dietary polyphenol ellagic acid is a potent inhibitor of hOAT1. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 33: 1097-100. PMID 15870380 DOI: 10.1124/Dmd.105.004275 |
0.521 |
|
2003 |
Whitley AC, Stoner GD, Darby MV, Walle T. Intestinal epithelial cell accumulation of the cancer preventive polyphenol ellagic acid--extensive binding to protein and DNA. Biochemical Pharmacology. 66: 907-15. PMID 12963477 DOI: 10.1016/S0006-2952(03)00413-1 |
0.535 |
|
Show low-probability matches. |